From: ron on
take a read of this!!!


ActoGeniX Is Progressing Toward Celiac Disease Treatment
Celiac.com 04/20/2008 - ActoGeniX is a recently formed Belgian company
specializing in the development and use of genetically altered
probiotic Lactococcus lactis bacteria designed to secrete and deliver
therapeutic peptides and proteins to treat gastrointestinal disorders.
Their product is called ActoBiotics�. Celiac disease is among the
disorders ActoGeniX is currently investigating. Research has already
shown efficacy in a celiac disease model where ActoBiotics�
continuously secrete small segments of gluten peptides to induce
tolerance to gluten. Further research and trials are in the pipeline.

Shortly after the release of a recent paper by Italian researchers
demonstrating that a peptide from durum wheat is able to completely
suppress the immune response to gluten in a culture of celiac disease
intestinal T cells (see Durum Wheat Peptide Could Lead To Celiac
Disease Treatment ), I contacted ActoGeniX to suggest they work with
the Italian researchers to create an ActoBiotic� designed to
continuously secrete the durum wheat peptide as a therapy for celiac
disease. ActoGeniX replied and was very interested in the durum wheat
peptide, indicating it was possible for them to produce an ActoBiotic�
to secrete the durum wheat peptide and they would contact the Italian
group. I also attempted to contact the Italian researchers to inform
them about ActoGeniX, but they did not reply. I strongly believe that
a collaboration between these two groups would result in the speediest
and most successful development of a treatment which could effectively
"cure" celiac disease through continuous secretion of the durum wheat
peptide by genetically modified probiotic bacteria in the gut.

ActoGeniX has recently totally revised their website which is now much
more informative and includes short videos discussing ActoBiotics� as
well as a short video presentation of their celiac disease research.
More about this article can be found on their website at
http://www.actogenix.com/eng/products/celiacdisease.php.

Technical information describing their product and initial research
and development in detail is presented in the following patent
application: http://www.freepatentsonline.com/WO2007063075.html.